Radiopharmaceuticals [clinicaltrials_resource:5ed8e445ec07740fbc1676b872d7cf35]
[F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children [clinicaltrials:NCT00556153]FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis [clinicaltrials:NCT00590395]Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab [clinicaltrials:NCT00613847]clinicaltrials:NCT01128023Positron Emission Tomography (PET)-Computed Tomography (CT) PET/CT Evaluation of Treatment Response in Breast Cancer [clinicaltrials:NCT01222416]clinicaltrials:NCT01359189Half-Dose Radiopharmaceutical in Wide Beam Reconstruction [clinicaltrials:NCT01499654]Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA [clinicaltrials:NCT01520025]Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and July 31, 2012 [clinicaltrials:NCT01763554]clinicaltrials:NCT01876771clinicaltrials:NCT02176720clinicaltrials:NCT02214862An Open Label Registry Study of Lutetium-177 (DOTA0, TYR3) Octreotate (Lu-DOTA-TATE) Treatment in Patients With Somatostatin Receptor Positive Tumours [clinicaltrials:NCT02236910]Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease [clinicaltrials:NCT02243982]clinicaltrials:NCT02325349clinicaltrials:NCT02441088
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Radiopharmaceuticals [clinicaltrials_resource:5ed8e445ec07740fbc1676b872d7cf35]
Bio2RDF identifier
5ed8e445ec07740fbc1676b872d7cf35
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5ed8e445ec07740fbc1676b872d7cf35
identifier
clinicaltrials_resource:5ed8e445ec07740fbc1676b872d7cf35
title
Radiopharmaceuticals
@en
type
label
Radiopharmaceuticals [clinicaltrials_resource:5ed8e445ec07740fbc1676b872d7cf35]
@en